Promising cell therapy offers hope for relapsed or refractory T-cell leukemia
Antileukemic activity of anti-CD7 PEBL-CAR T cells. Credit: Natural medicine (2024). DOI: 10.1038/s41591-024-03228-8 A new cell therapy, targeting CD7 in ...
Tag: relapsed
